The two low dosed forms of the preparation Premarin produced by the company “Wayet” intended for replacement hormonal therapy, are approved by Food and Drug Administration (FDA) for preventive maintenance of a postmenopausal bony rarefication. For today Premarin is accessible in various dozes for treatment of such symptoms of a postmenopausal period, as inflows, dryness, …
Fosamax (Alendronate)
In the longest of ever performed clinical researches in the treatment of postmenopause osteoporosis, a chronic disease which leads to reduction of bone weight and increase of frequency of fractures, scientists have established, that for women in postmenopause, which accepted FOSAMAX (alendron acid), the mineral density of bone fabric in a hip and in a …
Evista (Raloxifene)
The medical product Raloxifene (sold under name Evista), usually prescribed for preventive maintenance of a bony rarefication at women in the period after a menopause, can also lower the risk of disease by a cancer of a mammary gland at them almost on 70 % according to preliminary results presented at the annual assembly of …
